Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John Edward Robinson is active.

Publication


Featured researches published by John Edward Robinson.


Archive | 2004

Quinoline derivatives as phosphodiesterase inhibitors

Ian Baldwin; Michael David Barker; Anthony William Dean; Colin David Eldred; Brian GlaxoSmithKline Evans; Sharon Lisa GlaxoSmithKline Gough; Stephen Barry Guntrip; Julie Nicole Hamblin; Stuart GlaxoSmithKline Holman; Paul Jones; Mika Kristian GlaxoSmithKline Lindvall; Christopher James GlaxoSmithKline Lunniss; Tracy Jane GlaxoSmithKline Redfern; Alison Judith GlaxoSmithKline Redgrave; John Edward Robinson; Michael GlaxoSmithKline Woodrow


Archive | 2010

Benzpyrazole derivatives as inhibitors of p13 kinases

Ian Robert Baldwin; Kenneth David Down; Paul Faulder; Simon Gaines; Julie Nicole Hamblin; Katherine Louise Jones; Paul Spencer Jones; Joelle Le; Christopher James Lunniss; Nigel James Parr; Timothy John Ritchie; John Edward Robinson; Juliet Kay Simpson; Christian Alan Paul Smethurst


Archive | 2004

Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation

Christopher Glaxosmithkline D. Edlin; Colin David Eldred; Christopher James GlaxoSmithKline Lunniss; Alison J. Redgrave; John Edward Robinson; Michael GlaxoSmithKline Woodrow


Archive | 2003

Morpholinylmethylureas ccr-3 receptor antagonists

Michael Dennis Dowle; Paul Martin Gore; Simon Teanby Hodgson; Martin R. Johnson; Duncan Bruce Judd; Tracy Jane Redfern; John Edward Robinson; Stephen Swanson; Naimisha Trivedi


Archive | 2010

Indazole derivatives as pi 3 - kinase inhibitors

Ian Robert Baldwin; Kenneth David Down; Paul Faulder; Simon Gaines; Julie Nicole Hamblin; Katherine Louise Jones; Joelle Le; Christopher James Lunniss; Nigel James Parr; Timothy John Ritchie; John Edward Robinson; Christian Alan Paul Smethurst


Archive | 2006

Cinnoline Compounds as Inhibitors of Phosphodiesterase Type IV (Pde4)

Nicola Mary Aston; John Edward Robinson; Naimisha GlaxoSmithKline Trivedi


Archive | 2006

1,7-naphthyridines as pde4 inhibitors

Colin David Eldred; John Edward Robinson


Archive | 2003

PIPERAZINE DERIVATIVES AS ANTI-INFLAMMATORY AGENTS

Michael Dennis GlaxoSmithKline Dowle; Colin David Eldred; Martin Redpath GlaxoSmithKline Johnson; Tracy Jane GlaxoSmithKline Redfern; John Edward Robinson; Naimisha GlaxoSmithKline Trivedi; Victoria GlaxoSmithKline Weller


Archive | 2010

INDAZOLE DERIVATIVES AS PI 3-KINASE

Ian Robert Baldwin; Kenneth David Down; Paul Faulder; Simon Gaines; Julie Nicole Hamblin; Katherine Louise Jones; Joelle Le; Christopher James Lunniss; Nigel James Parr; Timothy John Ritchie; John Edward Robinson; Christian Alan Paul Smethurst


Archive | 2011

Derivados de indazol para su uso en el tratamiento de infección por virus de la gripe

Ian Robert Baldwin; Kenneth David Down; Paul Faulder; Simon Gaines; Julie Nicole Hamblin; Zoe Alicia Harrison; Katherine Louise Jones; Paul Spencer Jones; Suzanne Elaine Keeling; Joelle Le; Christopher James Lunniss; Charlotte Jane Mitchell; Nigel James Parr; Timothy John Ritchie; John Edward Robinson; Juliet Kay Simpson; Christian Alan Paul Smethurst; Yoshiaki Washio

Collaboration


Dive into the John Edward Robinson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge